Parexel’s Amy McKee, M.D. Named to 2023 PharmaVoice 100

Company’s Chief Medical Officer and FDA veteran receives distinguished award for notable contributions to clinical research

DURHAM, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) — Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced that Chief Medical Officer and Global Head, Oncology Center of Excellence, Amy McKee, M.D., has been named to the PharmaVoice 100 list of influential people in the life sciences industry. Dr. McKee was recognized for her inspirational leadership qualities and commitment to guiding the next generation of industry leaders along with her leadership in creating breakthrough strategies for sponsors. During her tenure at Parexel she has been instrumental in providing patient-led medical and scientific expertise in support of the company’s therapeutic and regulatory strategies. 

“The growing need for innovative, life-saving treatment options requires skilled leaders with the experience and patient-led focus to bring them to fruition,” said Peyton Howell, Chief Operating and Growth Officer. “Amy’s dedication to our customers, patients and the Parexel organization is an inspiration to anyone who has the pleasure of working with her. We look forward to her continued leadership and contributions in driving the industry forward to improve patient lives.” 

As the Chief Medical Officer and Global Head, Oncology Center of Excellence for Parexel, Dr. McKee provides oversight to the company’s therapeutic, medical and scientific centers of excellence. In this role, she collaborates closely with key stakeholders to strengthen Parexel as a collaborative drug development partner and establish market-leading, patient-focused teams. Since assuming the position of Chief Medical Officer in 2022, Dr. McKee has grown her team to include new therapeutic heads of Oncology, Hematology, Infectious Disease and Vaccines, and Neurosciences.  

With more than 20 years of experience in the life sciences — including FDA, regulatory, clinical research, bench science and clinical medicine expertise — Dr. McKee is an industry trailblazer with a deep-rooted passion for science and patients. She joined Parexel in 2019 as Vice President, Regulatory Consulting Services after an 11-year tenure with the FDA, during which time she served as Deputy Center Director, Oncology Center of Excellence; Supervisory Associate Director, Office of Hematology and Oncology Products (OHOP); and Acting Deputy Office Director of OHOP. Her vast FDA experience equips her well to lead Parexel in designing and implementing complex and innovative clinical development programs across various therapeutic areas. Dr. McKee received her M.D. from Tulane University School of Medicine and currently serves on the Board of Directors for BioCryst Pharmaceuticals, Inc.  

Since its inception in 2005, the PharmaVoice 100 highlights outstanding individuals across the industry who serve as sources of inspiration to their teams, companies and communities. Each honoree of the PharmaVoice 100 has been nominated and selected based on substantive personal accounts describing how they have profoundly motivated and inspired their colleagues and peers in their respective fields.  

To view the full list of PharmaVoice 100 honorees, click here.  

About Parexel

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With Heart^TM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com and follow us on LinkedIn, Twitter, Facebook and Instagram. 

MEDIA
Lori Preuit Dorer
Senior Vice President, Corporate Communications
+1 513 496 8121
Lori.Dorer@parexel.com

Danaka Williams
Director, Corporate Communications
+1 984 298 4207
Danaka.Williams@parexel.com